EPIC study highlights Mediterranean diet impact on obesity-linked cancer risk

Higher adherence to the Mediterranean diet is associated with a modest reduction in the risk of obesity-related cancers, ...
Seeking Alpha

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting

The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
MedPage Today

FcRn Blockers Go Head-to-Head in Myasthenia Gravis Trial

The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting treatments for generalized myasthenia gravis (gMG) in adults. The phase ...
News Medical

Mediterranean diet reduces risk of obesity-related cancers

New research reveals that following a Mediterranean diet may reduce the risk of obesity-linked cancers, including liver and kidney cancer. The study suggests that even moderate adherence offers some ...